SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Javier Ampuero, Manuel Romero-Gómez, Hepatitis C Virus, Gastroenterology Clinics of North America, 2015,

    CrossRef

  2. 2
    Carol Stanciu, Anca Trifan, Hepatitis C Virus Treatment Revolution: Eastern European Story, Hepatitis Monthly, 2015, 15, 7

    CrossRef

  3. 3
    Dorothée Obach, Yazdan Yazdanpanah, Gamal Esmat, Anchalee Avihingsanon, Sahar Dewedar, Nicolas Durier, Alain Attia, Wagida A. Anwar, Anthony Cousien, Pisit Tangkijvanich, Serge Paul Eholié, Wahid Doss, Aya Mostafa, Arnaud Fontanet, Mostafa K. Mohamed, Sylvie Deuffic-Burban, How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries, Hepatology, 2015, 62, 1
  4. 4
    Edoardo G Giannini, Nezam H Afdhal, Samuel H Sigal, Andrew J Muir, K Rajender Reddy, Shanthi Vijayaraghavan, Magdy Elkashab, Manuel Romero-Gómez, Geoffrey M Dusheiko, Malini Iyengar, Sandra Y Vasey, Fiona M Campbell, Dickens Theodore, Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy, Journal of Gastroenterology and Hepatology, 2015, 30, 8
  5. 5
    Wael Abdel-Razek, Imam Waked, Optimal therapy in genotype 4 chronic hepatitis C: finally cured?, Liver International, 2015, 35,
  6. 6
    Marc Bourlière, Souad Benali, Christelle Ansaldi, Gaelle Le Folgoc, Aurelie Riso, Laurence Lecomte, Optimal therapy of genotype-2 chronic hepatitis C: what's new?, Liver International, 2015, 35,
  7. 7
    Amr Shaaban Hanafy, Alaa Ahmad Farag, Hassan Mahmoud Hassanin, Ahmad Mahmoud Hassaneen, Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti-HCV combination therapy, Journal of Medical Virology, 2015, 87, 11
  8. 8
    M. Buti, J. Llaneras, M. Riveiro-Barciela, R. Esteban, Therapy for hepatitis C genotype 3: moving forward, Journal of Viral Hepatitis, 2015, 22, 9
  9. 9
    José Velosa, Fátima Serejo, Fernando Ramalho, Rui Marinho, Beatriz Rodrigues, Cilénia Baldaia, Miguel Raimundo, Paula Ferreira, A practical guide for antiviral therapy of chronic Hepatitis C, GE Portuguese Journal of Gastroenterology, 2014, 21, 6, 221

    CrossRef

  10. 10
    Andrew J. Muir, Sanjeev Arora, Gregory Everson, Robert Flisiak, Jacob George, Reem Ghalib, Stuart C. Gordon, Todd Gray, Susan Greenbloom, Tarek Hassanein, Jan Hillson, Maria Arantxa Horga, Ira M. Jacobson, Lennox Jeffers, Kris V. Kowdley, Eric Lawitz, Stefan Lueth, Maribel Rodriguez-Torres, Vinod Rustgi, Lynn Shemanski, Mitchell L. Shiffman, Subasree Srinivasan, Hugo E. Vargas, John M. Vierling, Dong Xu, Juan C. Lopez-Talavera, Stefan Zeuzem, A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection, Journal of Hepatology, 2014, 61, 6, 1238

    CrossRef

  11. 11
    Simona Francioso, Cristiana Almerighi, Paolo Forte, Franco Bandiera, Lorenzo Nosotti, Raffaella Lionetti, Gloria Taliani, Maria Rosaria Piras, Maria Laura Ponti, Giustino Parruti, Francesco Di Candilo, Silvia Gentile, Paola Piccolo, Angela Salso, Francesca Riccobelli, Sara Renzi, Maria Antonella Longo, Marzia Montalbano, Salvatore Zaru, Elisa Biliotti, Francesco Di Masi, Francesco Santopaolo, Mario Angelico, A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial, Digestive and Liver Disease, 2014, 46, 2, 164

    CrossRef

  12. 12
    Peter Ferenci, Rodrigo Aires, Ioan Ancuta, Andrew Arohnson, Hugo Cheinquer, Dragan Delic, Michael Gschwantler, Dominique Larrey, Ludovico Tallarico, Manuela Schmitz, Fernando Tatsch, Denis Ouzan, A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin, Liver International, 2014, 34, 10
  13. 13
    Pankaj Puri, Anil C. Anand, Vivek A. Saraswat, Subrat K. Acharya, Shiv K. Sarin, Radha K. Dhiman, Rakesh Aggarwal, Shivaram P. Singh, Deepak Amarapurkar, Anil Arora, Mohinish Chhabra, Kamal Chetri, Gourdas Choudhuri, Vinod K. Dixit, Ajay Duseja, Ajay K. Jain, Dharmesh Kapoor, Premashis Kar, Abraham Koshy, Ashish Kumar, Kaushal Madan, Sri P. Misra, Mohan V.G. Prasad, Aabha Nagral, Amarendra S. Puri, R. Jeyamani, Sanjiv Saigal, Samir Shah, Praveen K. Sharma, Ajit Sood, Sandeep Thareja, Manav Wadhawan, Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India, Journal of Clinical and Experimental Hepatology, 2014, 4, 2, 117

    CrossRef

  14. 14
    EASL Clinical Practice Guidelines: Management of hepatitis C virus infection, Journal of Hepatology, 2014, 60, 2, 392

    CrossRef

  15. 15
    Brian L. Pearlman, Carole Ehleben, Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitor, Hepatology, 2014, 59, 1
  16. You have free access to this content16
    Marc Bourlière, Xavier Adhoute, Astrid Wendt, Christelle Ansaldi, Valérie Oules, Paul Castellani, How to optimize current therapy of HCV genotype 1 infection with boceprevir, Liver International, 2014, 34,
  17. You have free access to this content17
    Sebastián Marciano, Adrián C. Gadano, How to optimize current treatment of genotype 2 hepatitis C virus infection, Liver International, 2014, 34,
  18. 18
    A. Aronsohn, I. Ancuta, F. Caruntu, C. Coppola, D. Delic, A. Digiacomo, G. M. Dusheiko, G. Lengyel, P. Marcellin, A. Orlandini, J. Pruthi, G. F. Silva, L. Tallarico, M. Schmitz, F. Tatsch, E. Korner, H. Cheinquer, Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort, Journal of Viral Hepatitis, 2014, 21, 5
  19. 19
    Alessandra Mangia, Tivadar Bányai, Giuseppe De Bartolomeo, Judit Gervain, François Habersetzer, Jean-Pierre Mulkay, Denis Ouzan, Giustino Parruti, Nicola Passariello, Andre-Jean Remy, Mario Rizzetto, Mitchell L. Shiffman, Alan D. Tice, Manuela Schmitz, Fernando Tatsch, Maribel Rodriguez-Torres, In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions, Liver International, 2014, 34, 7
  20. 20
    Ivan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia, Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus, Expert Opinion on Investigational Drugs, 2014, 23, 9, 1211

    CrossRef

  21. 21
    Nicolas Goossens, Francesco Negro, Is genotype 3 of the hepatitis C virus the new villain?, Hepatology, 2014, 59, 6
  22. 22
    Brittany E. Yee, Nghia H. Nguyen, Bing Zhang, Philip Vutien, Carrie R. Wong, Glen A. Lutchman, Mindie H. Nguyen, Meta-analysis, European Journal of Gastroenterology & Hepatology, 2014, 26, 11, 1189

    CrossRef

  23. 23
    Wael Abdel-Razek, Imam Waked, Optimal Management of HCV Genotype 4, Current Hepatology Reports, 2014, 13, 4, 286

    CrossRef

  24. 24
    Floriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, Maria Masocco, Alfonso Mele, Carmine Coppola, Michele Milella, Guglielmo Borgia, Pietro Andreone, Maurizio Koch, Anna Linda Zignego, Mario Romano, Maurizio Carrara, Piero Luigi Almasio, Emilio Azzola, Gerardo Nardone, Antonio Benedetti, Giampiero Carosi, Francesco Mazzotta, Evangelista Sagnelli, Mario Rizzetto, Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency, Digestive and Liver Disease, 2014, 46, 9, 826

    CrossRef

  25. You have free access to this content25
    A. F. Stättermayer, R. Strassl, A. Maieron, K. Rutter, R. Stauber, M. Strasser, S. Beinhardt, C. Datz, T.-M. Scherzer, P. Steindl-Munda, M. Gschwantler, M. Trauner, H. Hofer, P. Ferenci, Polymorphisms of interferon-λ4 and IL28B – effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2014, 39, 1
  26. 26
    Peter Ferenci, Rodrigo Aires, Kimberly L. Beavers, Manuela Curescu, Paulo R. Abrão Ferreira, Michael Gschwantler, Stefan Ion, Dominique Larrey, Mojca Maticic, Massimo Puoti, János Schuller, Istvan Tornai, Anna Tusnádi, Diethelm Messinger, Fernando Tatsch, Andrzej Horban, Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients, Hepatology International, 2014, 8, 1, 83

    CrossRef

  27. 27
    Stefan Zeuzem, Geoffrey M. Dusheiko, Riina Salupere, Alessandra Mangia, Robert Flisiak, Robert H. Hyland, Ari Illeperuma, Evguenia Svarovskaia, Diana M. Brainard, William T. Symonds, G. Mani Subramanian, John G. McHutchison, Ola Weiland, Hendrik W. Reesink, Peter Ferenci, Christophe Hézode, Rafael Esteban, Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3, New England Journal of Medicine, 2014, 370, 21, 1993

    CrossRef

  28. 28
    Antonio Rivero-Juarez, Karin Neukam, Pablo Labarga, Angela Camacho, Juan Macias, Pablo Barreiro, Julián Torre-Cisneros, Juan A. Pineda, Vicente Soriano, Antonio Rivero, Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy, Journal of Infection, 2014, 68, 4, 372

    CrossRef

  29. 29
    Massimo Colombo, Simone Strasser, Christophe Moreno, Paulo Abrao Ferreira, Petr Urbanek, Inmaculada Fernández, Djamal Abdurakmonov, Adrian Streinu-Cercel, Anke Verheyen, Wafae Iraqi, Ralph DeMasi, Andrew Hill, Isabelle Lonjon-Domanec, Heiner Wedemeyer, Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program, Journal of Hepatology, 2014, 61, 5, 976

    CrossRef

  30. 30
    Imam Waked, Waheed Doss, Manal Hamdy El-Sayed, Chris Estes, Homie Razavi, Gamal Shiha, Ayman Yosry, Gamal Esmat, The current and future disease burden of chronic hepatitis C virus infection in Egypt, Arab Journal of Gastroenterology, 2014, 15, 2, 45

    CrossRef

  31. 31
    Stefan Zeuzem, Federico J. Mensa, Concordance between sustained virologic response week 12 (SVR12) and SVR24 in genotype 1 hepatitis C virus patients receiving interferon-free treatment in the SOUND-C2 study, Hepatology, 2013, 58, 4
  32. 32
    Thomas-Matthias Scherzer, Albert Friedrich Stättermayer, Rudolf Stauber, Andreas Maieron, Michael Strasser, Hermann Laferl, Remy Schwarzer, Christian Datz, Karoline Rutter, Sandra Beinhardt, Petra Steindl-Munda, Harald Hofer, Peter Ferenci, Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients, Journal of Hepatology, 2013, 59, 5, 964

    CrossRef

  33. You have free access to this content33
    Eleonora Grassi, Alessio Aghemo, How to optimize HCV therapy in genotype 2 patients, Liver International, 2013, 33,
  34. 34
    Cheng-Yuan Peng, Nucleos(t)ide Analogues Therapy for Chronic Hepatitis B in Taiwan: Short-Term Versus Long-Term, Current Hepatitis Reports, 2013, 12, 3, 181

    CrossRef

  35. 35
    Vadim Brjalin, Riina Salupere, Tatjana Tallo, Tatiana Kuznetsova, Ljudmilla Priimägi, Valentina Tefanova, Predictors of treatment response in patients with hepatitis C 1b genotype, Open Medicine, 2013, 8, 6

    CrossRef

  36. 36
    Simona Bota, Ioan Sporea, Roxana Şirli, Adriana Maria Neghină, Alina Popescu, Mihnea Străin, Role of Interleukin-28B Polymorphism as a Predictor of Sustained Virological Response in Patients with Chronic Hepatitis C Treated with Triple Therapy: A Systematic Review and Meta-Analysis, Clinical Drug Investigation, 2013, 33, 5, 325

    CrossRef

  37. 37
    Ira M. Jacobson, Stuart C. Gordon, Kris V. Kowdley, Eric M. Yoshida, Maribel Rodriguez-Torres, Mark S. Sulkowski, Mitchell L. Shiffman, Eric Lawitz, Gregory Everson, Michael Bennett, Eugene Schiff, M. Tarek Al-Assi, G. Mani Subramanian, Di An, Ming Lin, John McNally, Diana Brainard, William T. Symonds, John G. McHutchison, Keyur Patel, Jordan Feld, Stephen Pianko, David R. Nelson, Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options, New England Journal of Medicine, 2013, 368, 20, 1867

    CrossRef